- Home
- KZR vs LOAN Comparison
KZR vs LOAN Comparison
Compare KZR & LOAN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZR
- LOAN
- Stock Information
- Founded
- KZR 2015
- LOAN 1989
- Country
- KZR United States
- LOAN United States
- Employees
- KZR N/A
- LOAN N/A
- Industry
- KZR Biotechnology: Pharmaceutical Preparations
- LOAN Real Estate Investment Trusts
- Sector
- KZR Health Care
- LOAN Real Estate
- Exchange
- KZR Nasdaq
- LOAN Nasdaq
- Market Cap
- KZR 54.1M
- LOAN 61.4M
- IPO Year
- KZR 2018
- LOAN 1999
- Fundamental
- Price
- KZR $6.43
- LOAN $5.60
- Analyst Decision
- KZR Hold
- LOAN
- Analyst Count
- KZR 2
- LOAN 0
- Target Price
- KZR $11.00
- LOAN N/A
- AVG Volume (30 Days)
- KZR 61.0K
- LOAN 17.9K
- Earning Date
- KZR 11-12-2024
- LOAN 10-23-2024
- Dividend Yield
- KZR N/A
- LOAN 8.26%
- EPS Growth
- KZR N/A
- LOAN 6.53
- EPS
- KZR N/A
- LOAN 0.49
- Revenue
- KZR N/A
- LOAN $7,394,068.00
- Revenue This Year
- KZR N/A
- LOAN N/A
- Revenue Next Year
- KZR N/A
- LOAN N/A
- P/E Ratio
- KZR N/A
- LOAN $11.37
- Revenue Growth
- KZR N/A
- LOAN 5.79
- 52 Week Low
- KZR $5.20
- LOAN $4.60
- 52 Week High
- KZR $11.40
- LOAN $5.90
- Technical
- Relative Strength Index (RSI)
- KZR 28.75
- LOAN 67.44
- Support Level
- KZR $6.80
- LOAN $5.55
- Resistance Level
- KZR $7.04
- LOAN $5.75
- Average True Range (ATR)
- KZR 0.24
- LOAN 0.09
- MACD
- KZR -0.06
- LOAN 0.02
- Stochastic Oscillator
- KZR 0.00
- LOAN 83.22
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
About LOAN Manhattan Bridge Capital Inc
Manhattan Bridge Capital Inc is a real estate finance company taxed as a REIT that specializes in originating, servicing and managing a portfolio of first mortgage loans. The company offers short-term, secured, non-banking loans which may renew or extend, before or after their initial term expires, to real estate investors to fund their acquisition, renovation, rehabilitation or development of residential or commercial properties located in the New York metropolitan area, including New Jersey and Connecticut, and in Florida.